EU visit to vaccine plant under scrutiny over AstraZeneca delays

EU visit to vaccine plant under scrutiny over AstraZeneca delays

The site at Seneffe, south of Brussels, manufactures the active ingredient of AstraZeneca's COVID-19 vaccine.


User: euronews (in English)

Views: 535

Uploaded: 2021-02-10

Duration: 01:50